LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

HIV Relies on Host Proteins to Clear the Way to the Nucleus

By LabMedica International staff writers
Posted on 06 Jul 2016
Image: HIV-1 viral cores (red) accumulate around the cell nucleus (blue) but remain unable to enter following depletion of the motor protein KIF5B (Photo courtesy of Loyola University Chicago).
Image: HIV-1 viral cores (red) accumulate around the cell nucleus (blue) but remain unable to enter following depletion of the motor protein KIF5B (Photo courtesy of Loyola University Chicago).
The ability of HIV to transit the cytoplasm and enter the nucleus of an infected cell was found to depend on the combined activities of two host proteins, the Kinesin-1 motor protein, KIF5B, and the nuclear pore component Nup358.

Following envelope mediated fusion, the HIV-1 nuclear core is released into the cytoplasm of the target cell and undergoes a series of modifications that result in the nuclear import of the viral genome, which ultimately leads to the integration of viral DNA into the host cell genome. Previous studies had found that disruption of microtubules, or depletion of dynein or kinesin motor proteins, perturbed the normal uncoating and trafficking of the viral genome.

In the current study, which was published in the June 21, 2016, online edition of the journal PLOS Pathogens, investigators at Loyola University (Chicago, IL, USA) enhanced the understanding of how HIV infection progresses by showing that the Kinesin-1 motor protein, KIF5B, induced a relocalization of the nuclear pore component Nup358 into the cytoplasm during HIV-1 infection. This relocalization of NUP358 was dependent on the HIV-1 capsid. NUP358 directly associated with viral cores following cytoplasmic translocation.

The interaction between NUP358 and the HIV-1 core was dependent on multiple capsid binding surfaces, as this association was not observed following infection with capsid mutants in which a conserved hydrophobic binding pocket (N74D) or the cyclophilin A binding loop (P90A) was disrupted. KIF5B knockdown also prevented the nuclear entry and infection by HIV-1, but did not exert a similar effect on the N74D or P90A capsid mutants, which do not rely on Nup358 for nuclear import.

Results obtained during these studies revealed a novel role for the microtubule motor protein KIF5B in the nuclear import of the viral genome and identified potential drug therapeutic intervention targets.

Related Links:
Loyola University


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Radial Immunodiffusion Assay
Radial Immunodifusion - C3 ID
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more